Abstract
Objective: Herpes simplex virus type 1 thymidine kinase (HSV1-tk) gene in combination with radiolabeled nucleoside substrates is the most widely used reporter system. This study characterized 1-(2'-deoxy-2'-[ 18F]fluoro-β-d-arabinofuranosyl)-5-iodocytosine ( 18F-FIAC) as a new potential positron emission tomography (PET) probe for HSV1-tk gene imaging and compared it with 2'-deoxy-2'-[ 18F]fluoro-5-iodo-1-β-D-arabinofuranosyluracil ( 18F-FIAU) and 2'-deoxy-2'-[ 18F]fluoro-5-ethyl-1-β-D-arabinofuranosyluracil( 18F-FEAU) (thymidine analogues) in an NG4TL4-WT/STK sarcoma-bearing mouse model. Methods: A cellular uptake assay, biodistribution study, radioactive metabolites assay and microPET imaging of NG4TL4-WT/STK tumor-bearing mice post administration of 18F-FIAC, 18F-FIAU and 18F-FEAU were conducted to characterize the biological properties of these tracers. Results: Highly specific uptake of 18F-FIAC, 18F-FIAU and 18F-FEAU in tk-transfected [tk(+)] cells was observed. The tk(+)-to-tk(-) cellular uptake ratio after a 2-h incubation was 66.6±25.1, 76.3±18.2 and 247.2±37.2, respectively. In biodistribution studies, 18F-FIAC showed significant tk(+) tumor specificity (12.6; expressed as the tk(+)-to-tk(-) tumor uptake ratio at 2 h postinjection) comparable with 18F-FIAU (15.8) but lower than 18F-FEAU (48.0). The results of microPET imaging also revealed the highly specific accumulation of these three radioprobes in the NG4TL4-tk(+) tumor. Conclusion: Our findings suggested that the cytidine analogue 18F-FIAC is a new potential PET probe for the imaging of HSV1-tk gene expression. 18F-FIAC may be regarded as the prodrug of 18F-FIAU in vivo.
Original language | English (US) |
---|---|
Pages (from-to) | 987-995 |
Number of pages | 9 |
Journal | Nuclear Medicine and Biology |
Volume | 38 |
Issue number | 7 |
DOIs | |
State | Published - Oct 2011 |
Keywords
- F-FEAU
- F-FIAC
- HSV1-tk
- MicroPET
- Nucleoside
- Reporter probe
ASJC Scopus subject areas
- Molecular Medicine
- Radiology Nuclear Medicine and imaging
- Cancer Research